Cytotoxic activity of the amphibian ribonucleases onconase and r-amphinase on tumor cells from B cell lymphoproliferative disorders

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 419-425

  Smolewski, Piotr ^a   Witkowska, Magdalena ^a   Zwolinska, Malgorzata ^a   Cebula Obrzut, Barbara ^a   Majchrzak, Agata ^a   Jeske, Aleksandra ^a   Darzynkiewicz, Zbigniew ^b   Ardelt, Wojciech ^c   Ardelt, Barbara ^c   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c TAmiR Biotechnology Inc   (United States)

Author keywords

Anticancer properties; Apoptosis; Onconase; r amphinase; Rana pipiens

Indexed keywords

AMPHINASE; RANPIRNASE; RIBONUCLEASE; UNCLASSIFIED DRUG; AMPHINASE, RANA PIPIENS; ANTINEOPLASTIC AGENT; DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; MONOTHERAPY; MULTIPLE MYELOMA; MULTIPLE MYELOMA CELL LINE; PRIORITY JOURNAL; B LYMPHOCYTE; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; LYMPHOPROLIFERATIVE DISEASE; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; YOUNG ADULT;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RIBONUCLEASES; YOUNG ADULT;

EID: 84902585419     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2405     Document Type: Article

References (28)

1. Arnold U and Ulbrich-Hofmann R: Natural and engineered ribonucleases as potential cancer therapies. Biotechnol Lett 28: 1615-1622, 2006.
2. Leland PA and Raines RT: Cancer chemotherapy - ribonucleases to the rescue. Chem Biol 8: 405-413, 2001.
3. Leland PA, Schultz LW, Kim BM, et al: Ribonuclease A variants with potent cytotoxic activity. Proc Natl Acad Sci USA 95: 10407-10112, 1998.
4. Turcotte RF and Raines RT: Interaction of onconase with the human ribonuclease inhibitor protein. Biochem Biophys Res Commun 377: 512-514, 2008.
5. Singh UP, Ardelt W, Saxena SK, et al: Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes. J Mol Biol 371: 93-111, 2007.
6. Ardelt W, Mikulski SM and Shogen K: Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases. J Biol Chem 266: 245-251, 1991.
7. Dyer KD and Rosenberg HF: The RNase a superfamily: generation of diversity and innate host defense. Mol Divers 10: 585-597, 2006.
8. Ardelt W, Shogen K and Darzynkiewicz Z: Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Curr Pharm Biotechnol 9: 215-225, 2008.
9. Zhao H, Ardelt B, Ardelt W, Shogen K and Darzynkiewicz Z: The cytotoxic ribonuclease onconase targets RNAi (siRNA). Cell Cycle 7: 3258-3261, 2008.
10. Mikulski SM, Viera A, Ardelt W, et al: Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P-30 protein, a novel protein possessing anti-tumor activity. Cell Tissue Kinet 23: 237-346, 1990.
11. Rybak SM, Pearson JW, Fogler WE, et al: Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. J Natl Cancer Inst 88: 747-753, 1996.
12. Smolewski P, Bedner E, Du L, Hsieh TC, Wu JM, Phelps DJ and Darzynkiewicz Z: Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 44: 73-82, 2001.
13. Ardelt W, Ardelt B and Darzynkiewicz Z: Ribonucleases as potential modalities in anticancer therapy. Eur J Pharmacol 625: 181-189, 2009.
14. Zwolińska M and Smolewski P: Onconase: a ribonuclease with antitumor activity. Post Hig Med Dosw 64: 58-66, 2009.
15. Michaelis M, Cinatl J, Anand P, et al: Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Lett 250: 107-116, 2007.
16. Pozarowski P, Huang X, Halicka DH, Lee B, Johnson G and Darzynkiewicz Z: Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells. A caution in data interpretation. Cytometry A 55: 50-60, 2003.
17. Ardelt B, Ardelt W, Pozarowski P, et al: Cytostatic and cytotoxic properties of amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes. Cell Cycle 6: 3097-3102, 2007.
18. Matoušek J: Ribonucleases and their antitumor activity. Comp Biochem Physiol 129C: 175-191, 2001.
19. Fredman P: Glycosphingolipid tumor antigens. Adv Lipid Res 25: 213-234, 1993.
20. Johnson RJ, Chao T-Y, Lavis LD, et al: Biochemistry 46: 10308-10316, 2007.
21. Mikulski SM, Viera A, Darzynkiewicz Z, et al: Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines. Br J Cancer 66: 304-310, 1992.
22. Deptala A, Halicka HD, Ardelt B, et al: Potentiation of tumor necrosis factor induced apoptosis by onconase. Int J Oncol 13: 11-16, 1998.
23. Ita M, Halicka HD, Tanaka T, Kurose A, Ardelt B, Shogen K and Darzynkiewicz Z: Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines. Cancer Biol Ther 7: 1104-1108, 2008.
24. Ardelt B, Ardelt W and Darzynkiewicz Z: Cytotoxic ribonucleases and RNA interference (RNAi). Cell Cycle 2: 22-24, 2003.
25. Ikemura K, Yamamoto M, Miyazaki S, Mizutani H, Iwamoto T and Okuda M: MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells. Mol Pharmacol 83: 399-405, 2013.
26. Zhu X, Li Y, Shen H, Li H, Long L, Hui L and Xu W: miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. Acta Biochim Biophys Sin (Shanghai) 45: 80-86, 2013.
27. Bao L, Hazari S, Mehra S, Kaushal D, Moroz K and Dash S: Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180: 2490-2503, 2012.
28. Costanzi J, Sidransky D, Navon A, et al: Ribonucleases as a novel pro-apoptotic anticancer strategy: Review of the preclinical and clinical data for Ranpirnase. Cancer Invest 23: 643-650, 2005.